Skip to main content
. 2022 Feb 4;35(5):592–599. doi: 10.1177/19714009211067400

Table 1.

Cross-sectional analysis of mean demographic scores and disease-related variables for RRMS (undergoing with two different types of disease-modifying therapies) and HCs groups at baseline.

Characteristics HCs (N = 19) RRMS (N = 37)
Sex (% female) 80% 78%
Age 35 ± 1.61 37 ± 1.21
Disease duration (years) 7 ± 1
EDSS 1.9 ± 0.15
MSSS 3.7 ± 0.3
ARR 1 ± 0.22
tARCS 90 ± 3.5 83 ± 2.7
Memory 90 ± 2.5 86 ± 3.8
Fluency 89 ± 4.3 79 ± 2.5*
Visuospatial 99 ± 0.63 102 ± 0.69*
Language 94 ± 4.12 85 ± 3.03
Attention 97 ± 2.1 94 ± 2.62
SDMT 64 ± 2.31 52 ± 1.75**
DASS-21 8 ± 1.62 28 ± 4.24**
Stress 5 ± 1.2 13 ± 1.90**
Anxiety 2 ± 0.52 8 ± 1.44**
Depression 2 ± 0.39 8 ± 1.50**
MFIS 12 ± 2.5 36 ± 3.03**
Physical fatigue 5 ± 0.93 18 ± 1.50**
Cognitive fatigue 7 ± 1.7 18 ± 1.65** 

Values are expressed in mean ± standard error of measurement.

HCs: healthy controls; MS: multiple sclerosis; EDSS: expanded disability status scale; MSSS: multiple sclerosis severity score; ARR: Annualised relapse rate; tARCS: total audio recorded cognitive screen; SDMT: Symbol Digit Modalities Test; DASS: depression, anxiety, stress scale; MFIS: modified fatigue impact scale.

*p-value ≤ .05, **p-value ≤ .01.